Pancreatic Cancer Research

ResearcherPeople’s Hospital of RizhaoNo recent work listed

Lingxin Meng

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper

Papers 4

  1. Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. Co-author DOI 10.1016/j.tice.2022.101867↗
  2. Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. Co-author DOI 10.1016/j.jpba.2021.114339↗
  3. Study on the expression profile and role of decorin in the progression of pancreatic cancer. Co-author DOI 10.18632/aging.203060↗
  4. Neurotrophic artemin promotes motility and invasiveness of MIA PaCa-2 pancreatic cancer cells. Co-author DOI 10.7314/apjcp.2012.13.5.1793↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Litao Zhang · 3 shared papers, 2021–2022 · strength 0.38
  2. Yuntao Zhang · 3 shared papers, 2021–2022 · strength 0.38
  3. Qiang Ren · 3 shared papers, 2021–2022 · strength 0.38
  4. Wei Qin · 3 shared papers, 2021–2022 · strength 0.38
  5. Huijie Gao · 2 shared papers, 2021–2022 · strength 0.25
  6. Sen Qiao · 2 shared papers, 2021–2022 · strength 0.25
  7. Jing Zhang · 1 shared paper, 2022 · strength 0.13
  8. Ying-jie Xue · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.